浏览全部资源
扫码关注微信
1.苏州大学附属第一医院药学部,江苏 苏州 215006
2.郑州大学第五附属医院药学部,郑州 450052
3.肇庆市第一人民医院药学部,广东 肇庆 526000
4.郑州大学附属郑州中心医院药学部,郑州 450007
5.淮安市第一人民医院药学部,江苏 淮安 223300
6.苏州大学附属第一医院肾内科,江苏 苏州 215006
7.贵阳市妇幼保健院药剂科,贵阳 550003
Published:15 November 2023,
Received:02 June 2023,
Revised:25 September 2023,
扫 描 看 全 文
杭永付,徐燕,戴小花等.腹膜透析患者全程智慧化药学服务模式的建立 Δ[J].中国药房,2023,34(21):2644-2648.
HANG Yongfu,XU Yan,DAI Xiaohua,et al.Establishment of whole-process intelligent pharmaceutical care model for peritoneal dialysis patients[J].ZHONGGUO YAOFANG,2023,34(21):2644-2648.
杭永付,徐燕,戴小花等.腹膜透析患者全程智慧化药学服务模式的建立 Δ[J].中国药房,2023,34(21):2644-2648. DOI: 10.6039/j.issn.1001-0408.2023.21.13.
HANG Yongfu,XU Yan,DAI Xiaohua,et al.Establishment of whole-process intelligent pharmaceutical care model for peritoneal dialysis patients[J].ZHONGGUO YAOFANG,2023,34(21):2644-2648. DOI: 10.6039/j.issn.1001-0408.2023.21.13.
目的
2
建立腹膜透析(PD)全程智慧化药学服务模式,为临床药师提供规范化PD药学服务提供参考。
方法
2
调研分析国内外PD患者的药学服务模式,结合苏州大学附属第一医院(以下简称“我院”)实际情况,以“居家→PD中心门诊→住院部”为主要节点,优化药物重整循环流程。通过改良汉化版的药物相关问题(DRPs)分类工具,制定相应的药学服务流程,展示具体案例等方面阐述PD全程智慧化药学服务模式。
结果
2
我院以药物治疗管理(MTM)平台为依托,构建了“在院药学监护(建档)-PD门诊MTM-居家药学服务(线上App管理)”的闭环PD全程智慧化药学服务模式,形成了“入院→出院→门诊”药物重整循环和“发现-分析-干预-随访-记录-评估”DRPs循环的“双循环”工作流程。
结论
2
我院PD全程智慧化药学服务模式的建立为规范PD患者的药学服务提供了经验,可以减少DRPs。
OBJECTIVE
2
To develop a whole-process intelligent model of pharmaceutical care for peritoneal dialysis (PD) patients, and to provide a reference for clinical pharmacists to provide standardized PD pharmaceutical care.
METHODS
2
The pharmaceutical care mode of PD patients at home and abroad was investigated and analyzed. Based on the actual situation of the First Affiliated Hospital of Soochow University (hereinafter referred to as “our hospital”), with “home→PD center outpatient→inpatient department” as the main node, the recycling process of medication reconciliation was optimized. The whole-process intelligent pharmaceutical care model of PD was illustrated by improving the Chinese version of the drug-related problems (DRPs) classification tool, developing the corresponding pharmaceutical care process, and presenting specific cases.
RESULTS
2
Based on the medication therapy management (MTM) platform, our hospital had built a closed-loop PD whole-process intelligent pharmaceutical care model of “in-hospital pharmaceutical care (building document)-PD outpatient MTM-home pharmaceutical care (online App management)”. A “double cycle” workflow of “admission→discharge→outpatient” medication reconciliation cycle and “discovery-analysis-intervention-follow-up-record-evaluation” DRPs cycle was formed.
CONCLUSIONS
2
The establishment of the whole-process intelligent pharmaceutical care model for PD in our hospital provides experience for standardizing pharmaceutical care for PD patients, and can reduce DRPs.
腹膜透析药学服务工作模式临床药师药物重整药物相关问题药物治疗管理
pharmaceutical carework modelclinical pharmacistmedication reconciliationdrug-related problemsmedication therapy management
《中国腹膜透析管理现状白皮书》项目组.中国腹膜透析管理现状白皮书[J]. 中华肾脏病杂志,2022,38(12):1076-1104.
Project Group of White Paper on the Status of Peritoneal Dialysis Management in China. White paper on the current status of peritoneal dialysis management in China[J]. Chin J Nephrol,2022,38(12):1076-1104.
ZHANG L X,ZHAO M H,ZUO L,et al. China kidney disease network (CK-NET) 2016 annual data report[J]. Kidney Int Suppl,2020,10(2):e97-e185.
ST PETER W L. Improving medication safety in chronic kidney disease patients on dialysis through medication reconciliation[J]. Adv Chronic Kidney Dis,2010,17(5):413-419.
徐丹,冯霞,陈丽金,等. 腹膜透析患者对药学服务需求的影响因素[J].中国临床药学杂志,2021,30(5):355-360.
XU D,FENG X,CHEN L J,et al. Influencing factors of peritoneal dialysis patients’ demand for pharmaceutical services[J]. Chin J Clin Pharm,2021,30(5):355-360.
MATZKE G R,ST PETER W L,COMSTOCK T J,et al. Nephrology pharmaceutical care preceptorship:a programmatic and clinical outcomes assessment[J]. Ann Pharmacother,2000,34(5):593-599.
MANLEY H J,AWEH G,WEINER D E,et al. Multidisciplinary medication therapy management and hospital readmission in patients undergoing maintenance dialysis:a re- trospective cohort study[J]. Am J Kidney Dis,2020,76(1):13-21.
PAI A B,CARDONE K E,MANLEY H J,et al. Medication reconciliation and therapy management in dialysis-dependent patients:need for a systematic approach[J]. Clin J Am Soc Nephrol,2013,8(11):1988-1999.
王庆,刘丹,周雅梅,等. 居家腹膜透析患者的药学延伸服务应用探索[J]. 解放军药学学报,2022,35(2):171-174.
WANG Q,LIU D,ZHOU Y M,et al. Extended pharmaceutical care for home peritoneal dialysis patients[J]. Pharm J Chin People’s Liberation Army,2022,35(2):171-174.
雷雯朴,白迎文,杨婷,等. 临床药师对腹膜透析患者实施肾性贫血药物治疗管理服务实践效果[J]. 中南药学,2023,21(4):1101-1106.
LEI W P,BAI Y W,YANG T,et al. Medication therapy management for peritoneal dialysis patients with renal anemia[J]. Cent South Pharm,2023,21(4):1101-1106.
丁跃辉,李伟,郑芳芳,等. 构建区域共享的门诊药师参与的腹膜透析液物流配送服务模式[J]. 中国医院药学杂志,2020,40(1):117-119.
DING Y H,LI W,ZHENG F F,et al. Establishment of a regional shared model for peritoneal dialysis solution logistics delivery service with outpatient pharmacists’ participation[J]. Chin J Hosp Pharm,2020,40(1):117-119.
徐丹,冯霞,陈丽金,等. 临床药师参与医药护联合门诊对腹膜透析患者的干预效果[J]. 中国医院药学杂志,2020,40(10):1165-1169.
XU D,FENG X,CHEN L J,et al. Intervention effect of clinical pharmacists participating in joint outpatient on peritoneal dialysis patients[J]. Chin J Hosp Pharm,2020,40(10):1165-1169.
赵瑞,杭永付,刘星星,等. 我院慢性肾脏病患者药物重整服务模式的建立[J]. 中国药学杂志,2020,55(5):408-412.
ZHAO R,HANG Y F,LIU X X,et al. Development of medication reconciliation model for chronic kidney di- sease in our hospital[J]. Chin Pharm J,2020,55(5):408-412.
王惠霞,朱旭婷,谢诚,等. 我院临床药师开展慢性肾脏病患者药物重整服务初探[J]. 中国药学杂志,2018,53(24):2148-2151.
WANG H X,ZHU X T,XIE C,et al. Primary medication reconciliation service provided by clinical pharmacist for chronic kidney disease in our hospital[J]. Chin Pharm J,2018,53(24):2148-2151.
LIU X X,WANG H X,HU Y Y,et al. Drug-related pro- blems identified by clinical pharmacists in nephrology department of a tertiary hospital in China:a single center study[J]. Ann Palliat Med,2021,10(8):8701-8708.
0
Views
9
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution